SCHEMBL4601374

SCHEMBL4601374

COc1cc(-c2cc(C(=O)N[C@H](CO)Cc3c[nH]c4ccc(C)cc34)c3ccccc3n2)cc(OC)c1OC

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
POLB P06746 3/20 0.51
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 1/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
TACR3 P29371 2/20 0.46
RAB9A P51151 1/20 0.46
UBE2I P63279 1/20 0.45
SAE1 Q9UBE0 1/20 0.45
UBA2 Q9UBT2 1/20 0.45
HTT P42858 1/20 0.45
DHODH Q02127 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4601369 1.00 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601366 1.00 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601433 0.94 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601437 0.94 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601429 0.94 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL14557577 0.94 MAPT (0.47) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601464 0.93 MAPT (0.54) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL4601818 0.93 MAPT (0.54) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL5155674 0.92 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA
SCHEMBL5155685 0.92 MAPT (0.51) MAPTPOLBKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R MAPT 4047/4885POLB 4403/4885KDM4E 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.